Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Ladanyi
    Ladanyi
  2. Arcila
    Arcila
  3. Berger
    Berger
  4. Nafa
    Nafa
  5. Razavi
    Razavi
  6. Ross
    Ross
  7. Aypar
    Aypar
  8. Birsoy
    Birsoy
  9. Carlo
    Carlo
  10. Chang
    Chang

Groups

  1. Department of Medicine (4)
  2. Early Drug Development Service (4)
  3. GSK Faculty (4)
  4. Human Oncology and Pathogenesis Program (4)
  5. Solid Tumor Oncology Division (4)
  6. Tow Center for Developmental Oncology (TCDO) (4)
  7. Breast Medicine Service (3)
  8. Center for Pancreatic Cancer Research (2)
  9. Clinical Genetics Service (1)
  10. GDMT, Pathology and Laboratory Medicine (1)
Search Within
  1. "Early Drug Development Service"
  2. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (3)
  2. Meeting Abstract (1)
Groups
  1. Department of Medicine (4)
  2. Early Drug Development Service (4)
  3. GSK Faculty (4)
  4. Human Oncology and Pathogenesis Program (4)
  5. Solid Tumor Oncology Division (4)
  6. Tow Center for Developmental Oncology (TCDO) (4)

More Groups

People
  1. David Hyman (4)
  2. Marc Ladanyi (4)
  3. Ahmet Zehir (3)
  4. Michael Berger (3)
  5. Ryma Benayed (3)
  6. Dara Ross (2)

More People

Years
  1. 2020 (1)
  2. 2019 (2)
  3. 2017 (1)
Publications
  1. Journal of Molecular Diagnostics (3)
  2. Lancet Oncology (1)

Results (4)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Larotrectinib in patients with TRK fusion-positive solid tumours: A pooled analysis of three phase 1/2 clinical trials
    Journal Article

    Hong, D. S.; DuBois, S. G.; Kummar, S.; Farago, A. F.; Albert, C. M.; Rohrberg, K. S.; van Tilburg, C. M.; Nagasubramanian, R.; Berlin, J. D.; Federman, N.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Integrated germline and somatic analysis identifies actionable cancer predisposing germline mutations in 9,734 patients with advanced cancers
    Meeting Abstract

    Jayakumaran, G.; Mandelker, D.; Birsoy, O.; Jairam, S.; Li, Y.; Yang, C.; Somar, J.; Rai, V.; Syed, A.; Benayed, R.; more...
    Journal of Molecular Diagnostics (2019)

    Fulltext@MSK | Save
  • Next-generation sequencing–based assessment of JAK2, PD-L1, and PD-L2 copy number alterations at 9p24.1 in breast cancer: Potential implications for clinical management
    Journal Article

    Gupta, S.; Vanderbilt, C. M.; Cotzia, P.; Arias-Stella, J. A. 3rd; Chang, J. C.; Zehir, A.; Benayed, R.; Nafa, K.; Razavi, P.; Hyman, D. M.; more...
    Journal of Molecular Diagnostics (2019)

    Fulltext@MSK | Save
  • Next-generation assessment of human growth factor receptor 2 (ERBB2) amplification status: Clinical validation in the context of a hybrid capture-based, comprehensive solid tumor genomic profiling assay
    Journal Article

    Ross, D. S.; Zehir, A.; Cheng, D. T.; Benayed, R.; Nafa, K.; Hechtman, J. F.; Janjigian, Y. Y.; Weigelt, B.; Razavi, P.; Hyman, D. M.; more...
    Journal of Molecular Diagnostics (2017)

    Fulltext@MSK | Save